Compare EME & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EME | A |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United States | United States |
| Employees | 25000 | N/A |
| Industry | Engineering & Construction | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7B | 38.0B |
| IPO Year | 1994 | 1999 |
| Metric | EME | A |
|---|---|---|
| Price | $772.39 | $147.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $831.67 | $161.47 |
| AVG Volume (30 Days) | 314.1K | ★ 1.6M |
| Earning Date | 04-29-2026 | 05-27-2026 |
| Dividend Yield | 0.19% | ★ 0.92% |
| EPS Growth | ★ 30.99 | 3.16 |
| EPS | ★ 15.89 | 3.55 |
| Revenue | ★ $16,986,422,000.00 | $4,472,000,000.00 |
| Revenue This Year | $7.85 | $8.45 |
| Revenue Next Year | $7.05 | $6.13 |
| P/E Ratio | $47.46 | ★ $42.49 |
| Revenue Growth | ★ 16.62 | 6.43 |
| 52 Week Low | $564.92 | $108.35 |
| 52 Week High | $951.96 | $163.75 |
| Indicator | EME | A |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 47.57 |
| Support Level | $686.80 | $135.76 |
| Resistance Level | $775.86 | $150.17 |
| Average True Range (ATR) | 22.99 | 4.91 |
| MACD | -1.93 | -1.31 |
| Stochastic Oscillator | 48.14 | 8.04 |
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.